BUSINESS
G20 Summit: India and WHO to launch Global Initiative on Digital Health
G20 New Delhi Summit: The initiative will be rolled out on August 19 to consolidate efforts in the digital healthcare landscape around the world.
BUSINESS
How Sun Pharma’s complaint helped authorities seize fake medicines worth Rs 2 cr
Call detail records (CDR) of one of the accused led the investigation team to a warehouse where the fake medicines were stored. The seizure found fakes of products of all top pharma companies. More raids are being planned.
BUSINESS
Pharma makers get a year for GMP implementation, Mandaviya warns action on defaults
The Union Health Minister said the observations from the ongoing Risk-Based Inspections by regulators necessitated a different approach for GMP regulations and quality management systems followed by drug makers.
BUSINESS
Top oncologists release national consensus guidelines for treating oral cancer
According to the GLOBOCAN 2020 report, India witnesses over 2.25 lakh new head and neck cancer cases every year out of which over 1.25 lakh deaths are reported every year
BUSINESS
Delhi stares at an epidemic as conjunctivitis cases spike
Sujeet Singh, former Director, National Centre of Disease Control says the focus should be on identifying the type of conjunctivitis prevailing.
BUSINESS
Top e-pharmacy CEOs back Centre’s move to regulate segment
Uncertainty has dented investor confidence and legislation will help restore it, say the CEOs.
INDIA
Centre plans to reduce specialist doctors shortage; PG, UG seats to be made equal
Acknowledging the shortage of specialist doctors in the country, a top health ministry official said the government has set a target of three years to bridge the existing gap
TRENDS
Cough syrup samples for export piling up at govt labs, Centre looks to rope in private facilities
Rajeev Singh Raghuvanshi, Drug Controller General of India, in two separate communications to drug exporters, informed about the pendency of more than 100 cough syrups for analysis in Ghaziabad and Mumbai testing facilities, requesting them not to send the samples to these labs.
TRENDS
Mandaviya bats for self-regulation by small pharma firms, says won’t compromise on drug quality
Mandaviya directed the Drugs Controller General of India (DCGI) to take stringent action against all pharmaceutical manufacturing companies involved in manufacturing of spurious drugs.
TRENDS
Drug quality concerns take centre stage at pharma export council’s global meet
Rajeev Raghuvanshi, DCGI, said that the non-uniform implementation of the Drugs and Cosmetics Act in the states was a challenge, but added that there was room for improvement.
BUSINESS
Quality the key to transform Indian Pharma
TRENDS
All you need to know about IARC, the agency that called out aspartame as a cancer link
INDIA
Sanofi to widen presence in India with more products: MD Rodolfo Hrosz
HEALTH-AND-FITNESS
MC Explains: Why foreign medical grads aren’t allowed registration in India
TRENDS
Fortis partners with RED.Health to augment emergency ambulance service in Delhi-NCR
TRENDS
Gennova's mRNA Omicron booster shot in India to be available at Rs 2,292
TRENDS
Quality concerns: Indian drug regulators probing 209 risky manufacturing sites, 45 in Himachal get notice
TRENDS
Heatwave crisis | Develop training manuals to prevent deaths, Mansukh Mandaviya tells affected states
INDIA
Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli
TRENDS
Heatwave crisis | Health Minister Mansukh Mandaviya chairs key meeting; five-member team to visit affected states
TRENDS
Exclusive: ICMR reviewing preliminary findings on link between Covid jabs and sudden heart attack deaths: DG Rajiv Bahl
TRENDS
World Sickle Cell Awareness Day: Can gene therapy be the silver bullet? An Indian start-up looks for a breakthrough
TRENDS
Diabetes and cardiovascular diseases account for over 33% of Jan Aushadhi medicine sales, reveals govt data
TRENDS
CERT-In denies CoWIN data breach to Parliament panel, say hackers collated data from different sources





